A study of human leukocyte antigen‐haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients

The clinical applications of human leukocyte antigen (HLA) haploidentical hematopoietic stem cells transplantation (haplo‐HSCT) have offered most of the young severe aplastic anemia (SAA) patients an opportunity to accept curative therapy at the early stage of bone marrow lesions. However, the outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Li, Han, Dong‐Mei, Zheng, Xiao‐Li, Yan, Hong‐Min, Xue, Mei, Liu, Jing, Zhu, Ling, Li, Sheng, Mao, Ning, Guo, Zi‐Kuan, Ning, Hong‐Mei, Wang, Heng‐Xiang, Zhu, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Standards, Protocols, Policies, and Regulations for Cell‐based Therapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848315/
https://www.ncbi.nlm.nih.gov/pubmed/32978903
http://dx.doi.org/10.1002/sctm.20-0345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848315/
https://www.ncbi.nlm.nih.gov/pubmed/32978903
http://dx.doi.org/10.1002/sctm.20-0345

Ejemplares similares